Longtime cancer researcher Charles Sawyers named first STAT Biomedical Innovation Award winner
MEMORIAL SLOAN KETTERING CANCER CENTER
Dr. Charles Sawyers played a major role in the development of the blockbuster drugs Gleevec for leukemia and Xtandi for prostate cancer.
No hay comentarios:
Publicar un comentario